Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors

2011715 citationsJournal Article

Authors

Shuichiro Shiina · The University of Tokyo

Ryosuke Tateishi · The University of Tokyo

Toru Arano · The University of Tokyo

Koji Uchino · The University of Tokyo

Kenichiro Enooku · The University of Tokyo

Hayato Nakagawa · The University of Tokyo

Yoshinari Asaoka ·

Abstract

RFA could be locally curative for HCC, resulting in survival for as long as 10 years, and was a safe procedure. RFA might be a first-line treatment for selected patients with early-stage HCC.

Topics & Keywords

Hepatocellular Carcinoma Treatment and Prognosis Liver Disease Diagnosis and Treatment Endoplasmic Reticulum Stress and Disease

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The American Journal of Gastroenterology

Volume 107, Issue 4, pp. 569-577

DOI: 10.1038/ajg.2011.425

Field-Weighted Citation Impact: 17.56